Chabiotech Co., Ltd. logo

Chabiotech Co., Ltd. (085660)

Market Open
11 Aug, 06:30
KOSDAQ KOSDAQ
9,670. 00
-180
-1.8274%
981.31B Market Cap
- P/E Ratio
- Div Yield
34,413 Volume
0 Eps
9,850
Previous Close
Add Transaction
Day Range
9,560 9,770
Year Range
9,260 15,990
Want to track 085660 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

085660 trading today lower at ₩9,670, a decrease of -1.8274% from yesterday's close, completing a monthly decrease of -34.2624% or -₩5,040. Over the past 12 months, 085660 stock lost -34.2624%.
085660 is not paying dividends to its shareholders.
The last earnings report, released on Feb 27, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -381.4385%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KOSDAQ (KRW).

085660 Chart

People also search for

HLB Inc.
39,900
-1.9656%
Pharmaresearch Co., Ltd.
424,500
+3.5366%
St Pharm Co., Ltd.
107,300
-0.6481%
Mezzion Pharma Co., Ltd.
61,300
+0.4918%
Hyundai Bioscience Co., Ltd.
7,630
+1.1936%

Chabiotech Co., Ltd. (085660) FAQ

What is the stock price today?

The current price is ₩9,670.00.

On which exchange is it traded?

Chabiotech Co., Ltd. is listed on KOSDAQ.

What is its stock symbol?

The ticker symbol is 085660.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 981.31B.

Has Chabiotech Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Chabiotech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Gyu-Beom Han CEO
KOSDAQ Exchange
KR7085660009 ISIN
KR Country
278 Employees
- Last Dividend
2 Jun 2014 Last Split
27 Dec 2005 IPO Date

Overview

Chabiotech Co.,Ltd., headquartered in Seoul, South Korea, is a pioneering bio company that specializes in the field of cell and gene therapy, focusing primarily on stem and immune cells. Founded in 2002, the company has established itself on both a national and international scale, dedicating its research and services to the development of innovative treatments for incurable diseases. Chabiotech extends its expertise in regenerative medicine, alongside offering comprehensive medical wellness programs. Furthermore, it equips its clients with advanced IT systems, consulting services for the Chaum model, maternal-centered genome testing, and personalized healthcare solutions, emphasizing its role in advancing the biotechnological and healthcare industries.

Products and Services

Chabiotech Co.,Ltd. offers a wide array of products and services designed to address the complex needs of its customers:

  • Umbilical Cord Blood Consignment Storage: This service focuses on storing umbilical cord blood which can be used in the treatment of various incurable diseases.
  • Regenerative Medicines, Immune Cell and Stem Cell Storage Services: These services comprise the preservation of important biological materials that can be used in future treatments for conditions such as aging and incurable diseases.
  • Medical Wellness Programs: Chabiotech provides comprehensive wellness programs that include fitness, spa treatments, and supplements, aimed at enhancing the overall health and well-being of individuals.
  • Customized Development, Production, Clinical, and Commercialization Services: Tailored to customers involved in research and development, these services support the complete lifecycle of biotechnological products, from conception to market.
  • IT System Construction and Operation: The company offers optimized IT solutions, ensuring effective management and operation of biotechnological infrastructures.
  • Consulting for Chaum Model Development: Chabiotech provides expert consulting for the development, operation, and expansion of the distinctive Chaum model, focusing on integrated healthcare.
  • Maternal-Centered Genome Testing and Personalized Healthcare: This area of service incorporates genetic testing and personalized medical solutions to cater to the unique health needs of mothers.
  • Development of Immune Cells: Innovative immune cells are developed for the treatment of conditions such as recurrent glioblastoma, solid cancer, with products like CBT101, CBT111, and CAR-NK.
  • Development of Stem Cells: Chabiotech is advancing in the development of stem cell therapies for a variety of conditions, including chronic back pain, premature ovarian failure, stroke, Parkinson’s disease, macular degeneration, and Stargardt's disease with products like CordSTEM-DD, CordSTEM-POI, CordSTEM-ST, CBT-NPC, and hESC-RPE.
  • IVF (Fertility) Services: Offering fertility solutions to assist individuals and couples in their journey to parenthood.
  • Cosmetics and Cosmetic Raw Materials: The company develops and supplies cosmetics and cosmetic raw materials, focusing on bioactive components for skin health and anti-aging.
  • Medical Devices and Supplies: Chabiotech manufactures and supplies a range of medical devices and supplies, ensuring quality and reliability.
  • Bioinsurance Storage: A service dedicated to the long-term storage of biological materials for future therapeutic use.
  • Research Services: The company extends its expertise to support various research initiatives, helping in the advancement of medical science and biotechnological development.

Contact Information

Address: 442 Dosan-daero, Seoul, South Korea
Phone: 82 3 1881 7400